The surging popularity of GLP-1 weight-loss drugs is quietly reshaping the $40 billion U.S. cannabis market, experts and ...
The rise of GLP-1 weight-loss drugs is impacting the U.S. cannabis market as consumer behaviors shift. Cannabis dispensaries are adapting by recommending lower-dose products. Research into GLP-1 drugs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results